Combination Regimen ‘Viable, Effective’ for Follicular Lymphoma

Combination Regimen ‘Viable, Effective’ for Follicular Lymphoma

Jeremy Slade Abramson, MD, provides perspective on the phase 3b MAGNIFY trial presented at the ASCO Annual Meeting.

More...
Poorer DLBCL Survival Outcomes Linked to Dual Expression of MYC, BCL2

Poorer DLBCL Survival Outcomes Linked to Dual Expression of MYC, BCL2

Dual expression of MYC and BCL2 was associated with worse survival among patients with GCB-like DLBCL.

More...
Prof. Marek Trněný, Charles University Hospital, Prague, CZ, on Highlights of MCL at ICML 2017

Prof. Marek Trněný, Charles University Hospital, Prague, CZ, on Highlights of MCL at ICML 2017

An interview from the International Conference on Malignant Lymphoma June 14-17, 2017 in Lugano, Switzerland.

More...

 

Global Database Search

 knowyoursubtype iconb   facebook2 twitter2 youtube1

logo europe

IN THE NODE

Updates

 

The information on this website is for general use only. Please consult your physician if you think you may have lymphoma or
require more detailed information on the best course of treatment for you.

Our website does not host any form of advertisement. Last updated: 05/30/17. Copyright © 2017 Lymphoma Coalition. All rights reserved.